SUMMARY 1) An increase of hemoglobin A2over 3% is regarded as one of the two fundamental manifestations of the commonest thalassemic mutant in the heterozygous condition i.e. thalassemia minima ortypical microcytemia(here indicated asMA), while the other element is represented by the characteristic ensemble of the morphological and functional alterations of the erythrocytes. This assumption is based on the fact that the infrequent cases of sharp dissociation between the two elementsi.e.i) red cells normality with A2above 3 % (mA), andii) microcytemia with normal levels of A2(Ma). run in families and cannot be easily explained as a partial manifestation of a typical microcytemic gene. 2) The unilocal origin of theMavariant seems to be well proved by the segregations from 5Ma×ma(normal) matings where 10Maand 9machildren have been observed. Moreover this variant has been detected among the relatives of a carrier of Hb H, born from aMa×mamating. This is in agreement with other recently published reports and strongly suggests that the relationship between Hb H andatypical microcytemia(with low A2) has a precise etiological significance. 3) The unilocal origin of themAvariant (normocytic thalassemia?) is at the moment less firmly established. However a family is described (matingmA×MA) where the father and one child show the samemAphenotype; moreover one other child is affected by constitutional microcytic anemia (Th. media). This finding supports the observations of Silvestroni and Bianco, who have already reported that a number of patients with intermediate thalassemic syndromes are born frommA×MAmatings. 4) At the moment no data exist which enable to decide whether the different thalassemias are mutations of the same or of different loci; however if they shall be shown to be allelic, the hypothesis must be kept in mind that the Thalassemia locus is a complex locus with more than one mutation sides, responsible for different but correlated aspects of the phenotype (red cell structure and A2level). 5) The new hemoglobin B2, is described which has been recently identified by Kunkel. Ceppellini, Dunn and Firsheim (unpublished data). Reasons are given for regarding B2as the product of a mutation at the locus which is responsable for the synthesis of A2(locusHb2), The relationship of allelism between A2and B2is a proof of the genetic heterogeneity of the hemoglobin of the normal adult and may be taken as a model suggesting the genetic heterogeneity of hemoglobin A, notwithstanding its apparent chemical omogeneity. 6) It is concluded that the conditions generally indicated as Thalassemias represent a genetically heterogeneous group, which have nonetheless to do with related metabolic processes. It is therefore suggested that the termThalassemiamay be mantained for indicating all hereditary defects which directly interfere with hemoglobinogenesis although not producing a specific abnormal hemoglobin.
No takes yet. Share an insight, caveat, or question.
R Ceppellini (1959) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: